ArticleBlood advances2020

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma.

Erin A Dean et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.